ATE305773T1 - Verfahren zur wiederherstellung des fettpolsters - Google Patents

Verfahren zur wiederherstellung des fettpolsters

Info

Publication number
ATE305773T1
ATE305773T1 AT01996361T AT01996361T ATE305773T1 AT E305773 T1 ATE305773 T1 AT E305773T1 AT 01996361 T AT01996361 T AT 01996361T AT 01996361 T AT01996361 T AT 01996361T AT E305773 T1 ATE305773 T1 AT E305773T1
Authority
AT
Austria
Prior art keywords
fat pad
restoring
host
fat
present
Prior art date
Application number
AT01996361T
Other languages
English (en)
Inventor
Eric Andre Desrosiers
Original Assignee
Biosyntech Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyntech Canada Inc filed Critical Biosyntech Canada Inc
Application granted granted Critical
Publication of ATE305773T1 publication Critical patent/ATE305773T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Eye Examination Apparatus (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Prostheses (AREA)
AT01996361T 2000-11-15 2001-11-14 Verfahren zur wiederherstellung des fettpolsters ATE305773T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24822800P 2000-11-15 2000-11-15
US24857000P 2000-11-16 2000-11-16
US10/055,493 US6989373B2 (en) 2000-11-15 2001-10-29 Method for restoring a fat-pad
PCT/CA2001/001586 WO2002039977A2 (en) 2000-11-15 2001-11-14 A method for restoring a foot fat-pad

Publications (1)

Publication Number Publication Date
ATE305773T1 true ATE305773T1 (de) 2005-10-15

Family

ID=27368850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01996361T ATE305773T1 (de) 2000-11-15 2001-11-14 Verfahren zur wiederherstellung des fettpolsters

Country Status (9)

Country Link
US (1) US6989373B2 (de)
EP (1) EP1339393B1 (de)
JP (1) JP2004517655A (de)
AT (1) ATE305773T1 (de)
AU (1) AU2002218081A1 (de)
CA (1) CA2429009C (de)
DE (1) DE60113874T2 (de)
ES (1) ES2250515T3 (de)
WO (1) WO2002039977A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1788970A2 (de) * 2004-08-20 2007-05-30 Artes Medical, Inc. Verfahren zur verabreichung von mikroteilchen in kombination mit autologen körperkomponenten
CA2722145A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
EP2296637B1 (de) 2008-04-24 2014-04-02 Medtronic, Inc Chitosan enthaltende schutz-zusammensetzung
CN102065849B (zh) 2008-04-24 2015-04-29 麦德托尼克公司 基于壳聚糖和氧化多糖的保护性凝胶
JP5738753B2 (ja) 2008-04-24 2015-06-24 メドトロニック，インコーポレイテッド 再水和可能な多糖粒子およびスポンジ
US8230620B2 (en) * 2009-02-26 2012-07-31 Brian Ebel Foot pad for relieving pain
US10239960B2 (en) 2015-06-10 2019-03-26 Rhodia Operations Phosphonated polysaccharides and gels and process for making same
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
FR3044557B1 (fr) 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
US12133930B2 (en) * 2017-05-24 2024-11-05 Theramicro, Llc System and methods for soft-tissue augmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911926A (en) * 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH

Also Published As

Publication number Publication date
WO2002039977A2 (en) 2002-05-23
US20020094959A1 (en) 2002-07-18
DE60113874T2 (de) 2006-07-13
AU2002218081A1 (en) 2002-05-27
EP1339393B1 (de) 2005-10-05
DE60113874D1 (de) 2006-02-16
WO2002039977A3 (en) 2002-10-31
CA2429009A1 (en) 2002-05-23
JP2004517655A (ja) 2004-06-17
CA2429009C (en) 2012-10-23
US6989373B2 (en) 2006-01-24
EP1339393A2 (de) 2003-09-03
ES2250515T3 (es) 2006-04-16

Similar Documents

Publication Publication Date Title
DE69717864D1 (de) Verfahren zur erhöhung der fettfestigkeit und zur verbesserung der fleischqualität bei tieren
ATE420947T1 (de) Gewebeimplant zur wiederherstellung von knorpelgewebe
ATE245032T1 (de) Verwendung von neurotoxinen in medikamenten zur behandlung von thyroidstörungen
ATE305773T1 (de) Verfahren zur wiederherstellung des fettpolsters
DE69936102D1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
DE60107889D1 (de) Verfahren zur Behandlung von Kautschukzusammensetzungen enthaltend Soja Fettsäure, Sonnenblumen Fettsäure und deren Mischungen
DE60116339D1 (de) Waschkit sowie verfahren zur kombinierten pflege und reinigung von gewebe
ATE317890T1 (de) Verfahren zur entfernung von unangenehmen flüchtigen wirkstoffen aus lecithin
DE60143061D1 (de) Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
MXPA04004170A (es) Tratamiento del sindrome de resitencia a la insulina y diabetes de tipo 2 con inhibidores de pde9.
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
ATE326239T1 (de) Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
HU905854D0 (en) New peptidase and isomerase inhibitors
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
DE60127545D1 (de) Verfahren zur deaktivierung von allergenen der hausstaubmilbe
ATE311192T1 (de) Verfahren zur behandlung von chronischen geschwüren
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
WO2001034172A3 (en) Methods and compositions for treating reward deficiency syndrome
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE69638281D1 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
DE60020304D1 (de) Anordnung und Verfahren zur Prüfung der Crimpqualität von Kontakten sowie Verfahren zur Besimmung des Reibungsverschleisses der Crimpmatritze
DE50105185D1 (de) Verfahren zur Herstellung von Dithiazolyldisulfiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties